Acute and chronic dysimmune polyneuropathies in the context of the COVID-19 pandemic: pathogenesis, features of the clinical picture, diagnosis and therapy (literature review)
Dysimmune polyneuropathies are the etiologically heterogeneous group of diseases with autoimmune damage to the peripheral nervous system. The rarity of these diseases doesn’t exclude the possibility of their development or exacerbation in patients infected with SARS‑CoV‑2, which will require timely...
Saved in:
| Main Authors: | A. E. Khrulev, N. A. Shiyanova, S. N. Sorokoumova, D. S. Kasatkin, V. N. Grigoryeva, K. M. Belyakov, E. S. Romanova, D. S. Yankevich |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-09-01
|
| Series: | Нервно-мышечные болезни |
| Subjects: | |
| Online Access: | https://nmb.abvpress.ru/jour/article/view/445 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Guillain-Barré syndrome as an early complication of a new coronavirus infection SARS-CoV-2 (clinical case)
by: K.Yu. Lytvyn, et al.
Published: (2022-09-01) -
Dynamics of the incidence of acute and chronic inflammatory polyneuropathies in adults in the Leningrad region
by: E. A. Skornyakova, et al.
Published: (2021-04-01) -
Inflammatory demyelinating polyneuropathies and patient management during the COVID-19 pandemic. Literature review
by: R. Bunevičiūtė, et al.
Published: (2020-06-01) -
Diagnostic criteria and therapeutic implications of rapid-onset demyelinating polyneuropathies
by: Wiktoria Rałowska-Gmoch, et al.
Published: (2024-12-01) -
Intravenous high-dose immunotherapy: practical recommendations for use in the treatment of neurological disimmune diseases
by: N. A. Suponeva, et al.
Published: (2015-12-01)